Browse > Article

Murine Models of Ulcerative Colitis  

Flynn, Christopher (Center for Molecular Medicine, Division of Gastroenterology, University of Connecticut Health Center)
Levine, Joel (Department of Medicine, Division of Gastroenterology, University of Connecticut Health Center)
Rosenberg, Daniel-W. (Center for Molecular Medicine, Division of Gastroenterology, University of Connecticut Health Center)
Publication Information
Archives of Pharmacal Research / v.26, no.6, 2003 , pp. 433-440 More about this Journal
Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease of unknown etiology limited to the large intestine. The disease is prevalent in industrial societies and is associated with specific ethnic populations. A number of murine models, each focused on distinct aspects of the disease process, were developed over the past 20 years to further our understanding of the pathogenesis of UC. These models have been and remain our best resource for the study of the disorder as a result of their homology to human UC and the ease in which they can be manipulated and examined. This review examines and distills what has been learned from these models and how this information is related back to human UC.
Keywords
Ulcerative colitis; Murine models; Colon; Cancer; Inflammation;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Autenrieth, I. B., Bucheler, N., Bohn, E., Heinze, G., and Horak, I., Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut, 41, 793-800 (1997)   DOI   ScienceOn
2 Brandwein, S. L., McCabe, R. P., Cong, Y., Waites, K. B., Ridwan, B. U., Dean, P. A., Ohkusa, T., Birkenmeier, E. H., Sundberg, J. P., and Elson, C. O., Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J. Immunol., 159, 44-52 (1997)   PUBMED
3 Burich, A., Hershberg, R., Waggie, K., Zeng, W., Brabb, T., Westrich, G., Viney, J. L., and Maggio-Price, L., Helicobacterinduced inflammatory bowel disease in IL-10 and T cell deficient mice. Am. J. Physiol., 281, G764-778 (2001)
4 Hiatt, R. A. and Kaufman, L., Epidemiology of inflammatory bowel disease in a defined northern California population. West. J. Med., 149, 541-546 (1988)
5 Hornquist, C. E., Lu, X., Rogers-Fani, P. M., Rudolph, U., Shappell, S., Birnbaumer, L., and Harriman, G. R., Gai2-deficient mice with colitis exhibit a local increase in memory CD4+ T cells and proinflammatory Th1-type cytokines. J. Immunol., 158, 1068-1077 (1997)   PUBMED
6 Maggio-Price, L., Shows, D., Waggie, K., Burich, A., Zeng, W., Escobar, S., Morrissey, P., and Viney, J. L., Helicobacter bilis infection accelerates and H. hepaticus infections delays the development of colitis in multiple drug resistance deficient (mdr1a-/-) mice. Am. J. Path., 160, 739-751 (2002)   DOI   ScienceOn
7 Mombaerts, P., Mizoguchi, E., Grusby, M. J., Glimcher, L. H., Bhan, A. K., and Tonegawa, S., Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell, 75, 275-282 (1993)   DOI   ScienceOn
8 Schorle, H., Holtschkle, T., Hunig, T., Schimpl, A., and Horak, I., Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature, 352, 621-624 (1991)   DOI   ScienceOn
9 Snider, D. P., Liang, H., Switzer, I., and Underdown, B. J., IgA production in MHC class II-deficient mice is primarily a function of $\beta$-1a cells. Inter. Imm., 11, 191-198 (1999)   DOI   ScienceOn
10 Thiebaut, F., Tsuruo, T., Hamada, H., Bgottesman, M. M., Pastan, I., and Willingham, M. C., Cellular localizaton of the multidrug resistance gene product in normal human tissues. Proc. Natl. Acad. Sci. USA, 84, 7735-7738 (1987)   DOI   ScienceOn
11 Mahler, M., Bristol, I. J., Leiter, E. H., Workman, A. E., Birkenmeier, E. H., Elson, C. O., and Sundberg, J. P., Differential susceptibility of inbred mouse strains to dextran sulfate sodiuminduced colitis. Am. J. Physiol., 274, G544-G551 (1998)   PUBMED
12 Ohman, L., Franzen, L., Rudolph, U., Harriman, G. R., and Hornquist, E. H., Immune activation in the intestinal mucosa before the onset of colitis in Gai2-deficient mice. Scand. J. Immunol., 52, 80-90 (2000)   DOI   ScienceOn
13 Jaffee, B. D., Manos, E. J., Collins, R. J., Czerniak, P. M., Favata, M. F., Magolda, R. L., Scherle, P. A., and Trzaskos, J. M., Inhibition of MAP kinase kinase (MEK) results in an antiinflammatory response in vivo. Biochem. Biophys. R. Comm., 268, 647-651 (2000)   DOI   ScienceOn
14 Rudolph, U., Finegold, M. J., Rich, S. S., Harriman, G. R., Srinivasan, Y., Brabet, P., Boulay, G., Bradley, A., and Birnbaumer, L., Ulcerative colitis and adenocarcinoma of the colon in Gai2-deficinet mice. Nat. Gen., 10, 143-150 (1995a)   DOI   ScienceOn
15 Stowe, S. P., Redmond, S. R., Stormont, J. M., Shah, A. N., Chessin, L. N., Segal, H. L., and Chey, W. Y., An epidemiologic study of inflammatory bowel disease in Rochester, New York. Gastroenterology, 98, 104-110 (1990)   DOI   PUBMED
16 Sundberg, J. P., Elson, C. O., Bedgian, H., and Birkenmeier, H., Spontaneous heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology, 107, 1726-1735 (1994)   DOI   PUBMED
17 Rudolph, U., Finegold, M. J., Rich, S. S., Harriman, G. R., Srinivasan, Y., Brabet, P., Bradley, A., and Birnbaumer, L., Gi2a protein deficiency: A model for inflammatory bowel disease. J. Clin. Immunol., 15, 101S-105S (1995b)   DOI   PUBMED
18 Waidmann, M., Allemand, Y., Lehmann, J., Genaro, S. D., Bucheler, N., Hamann, A, and Autenrieth, I. B., Microflora reactive IL-10 producing regulatory T cells are present in the colon of IL-2 deficient mice but lack efficacious inhibition of IFN-$\gamma$ and TNF-$\alpha$ production. Gut, 50, 170-179 (2002)   DOI   ScienceOn
19 Gillen, C. D., Walmsley, R. S., Prior, P., Andrews, H. A., and Allan, R. N., Ulcerative colitis and Crohn's disease: A comparison of the colorectal cancer risk in extensive colitis. Gut, 35, 1590-1592 (1994)   DOI   ScienceOn
20 Hermiston, M. L. and Gordon, J. I., Inflammatory bowel disease and adenomas in mice expressing a dominant negative Ncadherin. Science, 270, 1203-1207 (1995)   DOI   PUBMED   ScienceOn
21 Simpson, S. J., Mizoguchi, E., Allen, D., Bhan, A. K., and Terhost, C., Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur. J. Immunol., 25, 2618-2625 (1995)   DOI   ScienceOn
22 Desvignes, C., Bour, H., Nicolas, J. F., and Kaiserlain, D., Lack of oral tolerance but oral priming for contact sensitivity to dinitrofluorobenzene in major histocompatibility complex class II-deficient mice and in CD4(+) T cell-depleted mice. Eur. J. Imm., 26, 1756-1761, (1996)   DOI   ScienceOn
23 Ehrhardt, R. O., Ludviksson, B. R., Gray, B., Neurath, M., and Strober, W., Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol., 158, 566-573 (1997)   PUBMED
24 Ma, A., Datta, M., Margosian, E., Chen, J., and Horak, I., T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J. Exp. Med., 182, 1567-1572 (1995)   DOI   ScienceOn
25 Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., Berns, A. J. M., and Borst, P., Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491-502 (1994)   DOI   ScienceOn
26 Schultz, M., Tonkonogy, S. L., Sellon, R. K., Veltkamp, C., Godfrey, V. L., Kwon, J., Grenther, W. B., Balish, E., Horak, I., and Sartor, R. B., IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am. J. Physiol., 276, G1461-G1472 (1999)   PUBMED
27 Mizoguchi, A., Mizoguchi, E., Chiba, C., Spiekermann, G. M., Tonegawa, S., Nagler-Anderson, C., and Bhan, A. K., Cytokine imbalance and autoantibody production in T cell receptor-$\alpha$ mutant mice with inflammatory bowel disease. J. Exp. Med., 183, 847-856 (1996)   DOI   ScienceOn
28 McDonald, S. A. C., Palmen, M. J. H. J., Van Rees, E. P., and MacDonald, T. T., Characterization of the mucosal cell mediated immune response in IL-2 knockout mice before and after the onset of colitis. Immunology, 91, 73-80 (1997)   DOI   ScienceOn
29 Shah, S. A., Simpson, S. J., Brown, L. F., Comiskey, M., de Jong, Y. P., Allen, D., and Terhorst, C., Development of colonic adenocarcinomas in a mouse model of ulcerative colitis-associated colon cancer. Gastroenterology, 120, A447 (2001)   DOI
30 Panwala, C. M., Jones, J. C., and Viney, J. L., A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J. Immunol., 161, 5733-5744 (1998)   PUBMED
31 Uhlig, H. H., Hornquist, E. H., Bache, L. O., Rudolph, U., Birnbaumer, L., and Mothes, T., Antibody response to dietary and autoantigens in Gai2-deficient mice. Eur. J. Gastro. Hepato., 13, 1421-1429 (2001)   DOI   ScienceOn
32 Gupta, S. K., Gallego, C., Johnson, G. L., and Heasley, L. E., MAP kinase is constitutively activated in gip2 and src transformed rat 1a fibroblasts. J. Biol. Chem., 267, 7987-7990 (1992)   PUBMED
33 Cong, Y., Brandwein, S. L., McCabe, R. P., Lazenby, A., Birkenmeier, E. H., Sundberg, J. P., and Elson, C. O., CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease. J. Exp. Med., 187, 855-864 (1998)   DOI   ScienceOn
34 Grusby, M. J., Johnson, R. S., Papaioannou, V. E., and Glimcher, L. H., Depletion of CD4+ T cells in major histocompatability complex class II deficient mice. Science, 253, 1417-1420 (1991)   DOI   PUBMED
35 Takashi, I., Kiyono, H., and Hamada, S., CD4+ T-cell population mediates development of inflammatory bowel disease in T-cell receptor a chain deficient mice. Gastroenterology, 112, 1876-1886 (1997)   DOI   PUBMED   ScienceOn
36 Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., and Horak, I., Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell, 75, 253-261 (1993)   DOI   ScienceOn
37 Mombaerts, P., Clarke, A. R., Hooper, M. L., and Tonewaga, S., Creation of a large genomic deletion at the T-cell antigen receptor $\beta$-subunit locus in mouse embryonic stem cells by gene targeting. Proc. Natl. Acad. Sci. USA, 88, 3084-3087 (1991)   DOI   ScienceOn
38 Elson, C. O., Cong, Y., and Sundberg J., The C3H/HeBir mouse model: a high susceptibility phenotype for colitis. Int. Rev. Immunol., 19, 63-75 (2000)   DOI   ScienceOn
39 Mombaerts, P., Clarke, A. R., Rudnicki, M. A., Iacomini, J., Itohara, S., LaFaille, J. J., Wang, L., Ichikawa, Y., Jaenisch, R., Hooper, M. L., and Tonegawa, S., Mutations in T-cell antigen receptor genes a and b block thymocyte development at different stages. Nature, 360, 225-231 (1992)   DOI   ScienceOn
40 Sohn, K., Shah, S. A., Reid, S., Choi, M., Carrier, J., Comiskey, M., Terhorst, C., and Kim, Y., Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and ${\beta}_2$-microglobulin-deficient mouse. Cancer Res., 61, 6912-6917 (2001)   PUBMED
41 Croop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., and Housman, D. E., The three mouse multidrug resistance (mdr) genes are expressed in a tissue specific manner in normal mouse tissue. Mol. Cell. Biol., 9, 1346-1350 (1989)   DOI   PUBMED